
TRIPTORELIN 11.25 mg Powder (Pamorelin LA) for Injection is a prescription gonadotropin-releasing hormone (GnRH) agonist used to treat advanced prostate cancer, endometriosis, uterine fibroids, central precocious puberty (CPP), and certain other hormone-sensitive conditions. It works by reducing the production of sex hormones, helping slow disease progression and relieve symptoms. The injection is administered by a healthcare professional at prescribed intervals.
| Generic name | TRIPTORELIN |
| Strength | 11.25 mg |
| Manufacturer | Dr Reddy’s Laboratories |
| Package size | 1.0 powder for injection in 1 vial |
| Used for | Advanced prostate cancer, endometriosis, uterine fibroids, central precocious puberty (CPP), and certain other hormone-sensitive conditions |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Georgia, Armenia, Saudi Arabia, Qatar, Kuwait, South Africa, and many other countries. |
Triptorelin 11.25 mg initially stimulates and then suppresses the release of gonadotropins from the pituitary gland. This leads to a significant reduction in testosterone levels in men and oestrogen levels in women. Lowering these hormones can slow the growth of hormone-dependent cancers and reduce symptoms associated with hormone-related conditions.
Dr. Neeru Mehta holds a Doctor of Medicine (MD) degree and has a professional interest in oncology and cancer care. Her interests include cancer treatments, monitoring treatment progress, managing side effects and supportive care.